drugset / Trial / NCT01518036
Use of Somatropin in Turner Syndrome
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is conducted in Europe. The aim of this trial is to study the dose-response relationship and effect of somatropin (Norditropin®) on final height in girls with Turner Syndrome.
Timeline
- Start
- 1987-09-14
- Primary completion
- 2004-04-11
- Completion
- 2004-04-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Somatropin | Protein / enzyme biologic | 2.9 unknown | Subcutaneous |
| Subject | Somatropin | Protein / enzyme biologic | 4.3 unknown | Subcutaneous |